National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$63.25
add to cart

Rights & Permissions

topleft topright

Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary (2005)
Board on Science, Technology, and Economic Policy (STEP)
National Cancer Policy Board (NCPB)

Citation Manager

. "Appendix B Workshop Participants." Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
37
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary

Appendix B
Workshop Participants

Todd Anderson, M.S.

Congressional Budget Office

Washington, DC

Elise Berliner, Ph.D.

Agency for Healthcare Research and Quality

Rockville, MD

Erica S.Breslau, Ph.D.

National Cancer Institute

Bethesda, MD

Durado Brooks, M.D.

American Cancer Society

Atlanta, GA

Martin L.Brown, Ph.D.

National Cancer Institute

Bethesda, MD

Kathleen Connors

“The Gray Sheet”

Chevy Chase, MD

Sarah Dash, M.P.H.

National Cancer Institute

Bethesda, MD

Robert S.Dittus, M.D.

Vanderbilt University Medical Center

Nashville, TN

Mary Doroshenk

American Cancer Society

Washington, DC

Donatus U.Ekwueme, Ph.D.

U.S. Centers for Disease Control and Prevention

Atlanta, GA

A.Mark Fendrick, M.D.

University of Michigan Health System

Ann Arbor, MI

Eric Feuer, Ph.D.

National Cancer Institute

Bethesda, MD

Alan Girling, M.D.

University of Birmingham

United Kingdom

Seth N.Glick, M.D.

Presbyterian Medical Center

Philadelphia, PA

Jay Herson

Westat

Rockville, MD

Inku Hwang, M.D.

Walter Reed Army Medical Center

Washington, DC

John M.Inadomi, M.D.

University of Michigan Medical Center

Ann Arbor, MI

Karen Kuntz, Sc.D.

School of Public Health Harvard University

Boston, MA

Uri Ladabaum, M.D., M.S.

University of California, San Francisco

San Francisco, CA

William Lawrence, M.D.

Agency for Healthcare Research and Quality

Rockville, MD

Page
37
Front Matter (R1-R8)
Workshop Summary (1-30)
References (31-34)
Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults (35-36)
Appendix B Workshop Participants (37-38)
Appendix C Workshop Speaker and Staff Biographies (39-44)
Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD. (45-60)
Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S. (61-72)
Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema (73-83)
Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus (84-104)
Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S. (105-117)
Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D., (118-153)
Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H. (154-188)
Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D. (189-207)
Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D. (208-219)
Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S. (220-231)
Appendix N Preliminary Results from CDC (232-240)
Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H. (241-262)
Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D. (263-284)
Appendix Q CISNET—Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D. (285-300)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 37
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary Appendix B Workshop Participants Todd Anderson, M.S. Congressional Budget Office Washington, DC Elise Berliner, Ph.D. Agency for Healthcare Research and Quality Rockville, MD Erica S.Breslau, Ph.D. National Cancer Institute Bethesda, MD Durado Brooks, M.D. American Cancer Society Atlanta, GA Martin L.Brown, Ph.D. National Cancer Institute Bethesda, MD Kathleen Connors “The Gray Sheet” Chevy Chase, MD Sarah Dash, M.P.H. National Cancer Institute Bethesda, MD Robert S.Dittus, M.D. Vanderbilt University Medical Center Nashville, TN Mary Doroshenk American Cancer Society Washington, DC Donatus U.Ekwueme, Ph.D. U.S. Centers for Disease Control and Prevention Atlanta, GA A.Mark Fendrick, M.D. University of Michigan Health System Ann Arbor, MI Eric Feuer, Ph.D. National Cancer Institute Bethesda, MD Alan Girling, M.D. University of Birmingham United Kingdom Seth N.Glick, M.D. Presbyterian Medical Center Philadelphia, PA Jay Herson Westat Rockville, MD Inku Hwang, M.D. Walter Reed Army Medical Center Washington, DC John M.Inadomi, M.D. University of Michigan Medical Center Ann Arbor, MI Karen Kuntz, Sc.D. School of Public Health Harvard University Boston, MA Uri Ladabaum, M.D., M.S. University of California, San Francisco San Francisco, CA William Lawrence, M.D. Agency for Healthcare Research and Quality Rockville, MD

OCR for page 38
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary Theodore R.Levin, M.D. Kaiser Permanente Medical Group Oakland, CA David Lieberman, M.D. Oregon Health and Sciences University Portland, OR Richard Lilford, M.D. University of Birmingham United Kingdom Diane Manninen, Ph.D Battelle Seattle, WA Dion Morton, M.D. University of Birmingham United Kingdom Brian P.Mulhall, M.D. Walter Reed Army Medical Center Washington, DC Reid M.Ness, M.D. Vanderbilt University Medical Center Nashville, TN Michael Pignone, M.D., M.P.H University of North Carolina-Chapel Hill Chapel Hill, NC George Provenzano, Ph.D. Battelle Arlington, VA Louise B.Russell, Ph.D. Rutgers University New Brunswick, NJ Howard Saft, M.D. VA Medical Center Washington, DC Robert Schoen, M.D. University of Pittsburgh Pittsburgh, PA Laura Seeff, M.D. Centers for Disease Control and Prevention Atlanta, GA Robert A.Smith, Ph.D. American Cancer Society Atlanta, GA Amnon Sonnenberg, M.D., M.Sc. Portland VA Medical Center Portland, OR Deborah Schrag, M.D., M.P.H. Memorial Sloan-Kettering Cancer Center New York, NY Marjolein van Ballegooijen, M.D. Erasmus Universiteit Rotterdam, The Netherlands Sally W.Vernon, Ph.D. University of Texas-Houston Health Science Center Houston, TX Sandeep Vijan, M.D. University of Michigan Health System Ann Arbor, MI Iris Vogelaar, M.Sc. Erasmus Medical Center Rotterdam, The Netherlands Judith L.Wagner, Ph.D. Institute of Medicine Washington, DC Ann Zauber, Ph.D. Memorial Sloan Kettering Cancer Center New York, NY

Representative terms from entire chapter:

ann arbor